Skip to Content
scroll

Thoughts on – CAJ, HLS & ING please?

Our Q&As are emailed in our Saturday Morning Report, find the answer to this question below.

The Latest Q&A

Question asked

Thoughts on – CAJ, HLS & ING please?

Hi James and Team Can I please have your thoughts on CAJ, HLS & ING Are these candidates to sell to cash up for potentially better opportunities. As you say we can't buy the whole market but your HIT lists are growing and will need funding to execute. Also can you mention the stocks held by MMatters being considered as sells to fund further purchases. regards Debbie

Answer

Hi Debbie,

Capitol Health (CAJ) 31.5c – MM remains long and bullish CAJ in our Emerging Companies Portfolio, we believe it looks good ~30c. Recent Medicare data is supportive of this thesis.

Healius (HLS) $3.36 – no change to our comments a month ago MM is neutral at best healthcare business HLS, they were a COVID beneficiary however we are unsure where earnings will land in a normal environment.

Inghams Group (ING) $2.40 – we believe this poultry stock’s finally offering value under $2.50 after falling more than 40% over the last 12-months but its unlikely to be on MM’s shopping list until inflationary pressures subside. These guys are feeling it at many stages of their production process from feed to transport and of course wages.

Overall our portfolios are largely in-line with our outlook into 2023 but a couple of potential sell / funding candidates are  TPG Telecom (TPG), Strandline (STA), Metcash (MTS) or Wesfarmers (WES)  and PointsBet (PBH).

 

chart
image description
Capital Health (CAJ)
image description

Relevant suggested news and content from the site

Back to top